Uncertainty in treatment rankings: Reanalysis of network meta-analyses of randomized trials

Annals of Internal Medicine

Volumn 164, Issue 10, 2016, Pages 666-673

  Trinquart, Ludovic ^a   Attiche, Nassima ^a   Bafeta, Aïda ^a   Porcher, Raphaël ^a   Ravaud, Philippe ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPARATIVE STUDY; CONSENSUS DEVELOPMENT; FOLLOW UP; HEURISTICS; HUMAN; PRIORITY JOURNAL; PROBABILITY; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; UNCERTAINTY; BAYES THEOREM; NETWORK META-ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS AND NUMERICAL DATA;

BAYES THEOREM; HUMANS; NETWORK META-ANALYSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84969963091     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M15-2521     Document Type: Article

References (99)

1. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23:3105-24. [PMID: 15449338]
2. Salanti G, Higgins JP, Ades AE, Ioannidis JP. Evaluation of networks of randomized trials. Stat Methods Med Res. 2008;17:279-301. [PMID: 17925316]
3. Salanti G, Kavvoura FK, Ioannidis JP. Exploring the geometry of treatment networks. Ann Intern Med. 2008;148:544-53. [PMID: 18378949]
4. Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods. 2012;3:80-97. [PMID: 26062083] doi:10.1002/jrsm.1037
5. Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011;64:163-71. [PMID: 20688472] doi:10.1016/j.jclinepi.2010.03.016
6. Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011;64:163-71. [PMID: 20688472] doi:10.1016/j.jclinepi.2010.03.016
7. Dias S, Sutton AJ, Ades AE, Welton NJ. Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making. 2013;33:607-17. [PMID: 23104435] doi:10.1177/0272989X12458724
8. Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162: 777-84. [PMID: 26030634] doi:10.7326/M14-2385
9. Jansen JP, Fleurence R, Devine B, Itzler R, Barrett A, Hawkins N, et al. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Value Health. 2011;14:417-28. [PMID: 21669366] doi:10.1016/j.jval.2011.04.002
10. Mills EJ, Ioannidis JP, Thorlund K, Schünemann HJ, Puhan MA, Guyatt GH. How to use an article reporting a multiple treatment comparison meta-analysis. JAMA. 2012;308:1246-53. [PMID: 23011714]
11. Sullivan SM, Coyle D, Wells G. What guidance are researchers given on how to present network meta-analyses to end-users such as policymakers and clinicians? A systematic review. PLoS One. 2014;9: e113277. [PMID: 25517510] doi:10.1371/journal.pone.0113277
12. Tan SH, Cooper NJ, Bujkiewicz S, Welton NJ, Caldwell DM, Sutton AJ. Novel presentational approaches were developed for reporting network meta-analysis. J Clin Epidemiol. 2014;67:672-80. [PMID: 24560089] doi:10.1016/j.jclinepi.2013.11.006
13. Mills EJ, Thorlund K, Ioannidis JP. Demystifying trial networks and network meta-analysis. BMJ. 2013;346:f2914. [PMID: 23674332] doi:10.1136/bmj.f2914
14. Bafeta A, Trinquart L, Seror R, Ravaud P. Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic review. BMJ. 2013;347:f3675. [PMID: 23818558] doi:10.1136/bmj.f3675
15. Bafeta A, Trinquart L, Seror R, Ravaud P. Reporting of results from network meta-analyses: methodological systematic review. BMJ. 2014;348:g1741. [PMID: 24618053] doi:10.1136/bmj.g1741
16. Veroniki AA, Vasiliadis HS, Higgins JP, Salanti G. Evaluation of inconsistency in networks of interventions. Int J Epidemiol. 2013;42:332-45. [PMID: 23508418] doi:10.1093/ije/dys222
17. Lu G, Ades AE. assessing evidence inconsistency in mixed treatment comparisons. Journal of the American Statistical Association. 2006;101:447-59.
18. Lu G, Ades AE, Sutton AJ, Cooper NJ, Briggs AH, Caldwell DM. Meta-analysis of mixed treatment comparisons at multiple follow-up times. Stat Med. 2007;26:3681-99. [PMID: 17285571]
19. Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010;29:932-44. [PMID: 20213715] doi:10.1002/sim.3767
20. Govan L, Ades AE, Weir CJ, Welton NJ, Langhorne P. Controlling ecological bias in evidence synthesis of trials reporting on collapsed and overlapping covariate categories. Stat Med. 2010;29: 1340-56. [PMID: 20191599] doi:10.1002/sim.3869
21. Ades AE, Mavranezouli I, Dias S, Welton NJ, Whittington C, Kendall T. Network meta-analysis with competing risk outcomes. Value Health. 2010;13:976-83. [PMID: 20825617] doi:10.1111/j.1524-4733.2010.00784.x
22. Lu G, Ades A. Modeling between-trial variance structure in mixed treatment comparisons. Biostatistics. 2009;10:792-805. [PMID: 19687150] doi:10.1093/biostatistics/kxp032
23. da Costa BR, Juni P. Systematic reviews and meta-analyses of randomized trials: principles and pitfalls. Eur Heart J. 2014;35:3336-45. [PMID: 25416325]
24. van Valkenhoef G, Tervonen T, de Brock B, Hillege H. Algorithmic parameterization of mixed treatment comparisons. Statistics and Computing. 2012;22(5):1099-111.
25. van Valkenhoef G, Lu G, de Brock B, Hillege H, Ades AE, Welton NJ. Automating network meta-analysis. Res Synth Methods. 2012;3:285-99. [PMID: 26053422] doi:10.1002/jrsm.1054
26. Salanti G, Del Giovane C, Chaimani A, Caldwell DM, Higgins JP. Evaluating the quality of evidence from a network meta-analysis. PLoS One. 2014;9:e99682. [PMID: 24992266] doi:10.1371/journal.pone.0099682
27. Norton EC, Miller MM, Wang JJ, Coyne K, Kleinman LC. Rank reversal in indirect comparisons. Value Health. 2012;15:1137-40. [PMID: 23244817] doi:10.1016/j.jval.2012.06.001
28. van Valkenhoef G, Ades AE. Evidence synthesis assumes additivity on the scale of measurement: response to "Rank reversal in indirect comparisons" by Norton et al [Letter]. Value Health. 2013;16: 449-51. [PMID: 23538198] doi:10.1016/j.jval.2012.11.012
29. Mills EJ, Kanters S, Thorlund K, Chaimani A, Veroniki AA, Ioannidis JP. The effects of excluding treatments from network meta-analyses: survey. BMJ. 2013;347:f5195. [PMID: 24009242] doi:10.1136/bmj.f5195
30. Jonas D, Wilkins T, Bangdiwala S, Bann C, Morgan L, Thaler K, et al. Findings of Bayesian mixed treatment comparison meta-analyses: comparison and exploration using real-world trial data and simulation. Methods research report. AHRQ publication no. 13-EHC039-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2013.
31. Kibret T, Richer D, Beyene J. Bias in identification of the best treatment in a Bayesian network meta-analysis for binary outcome: a simulation study. Clin Epidemiol. 2014;6:451-60. [PMID: 25506247] doi:10.2147/CLEP.S69660
32. Rücker G, Schwarzer G. Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Med Res Methodol. 2015;15:58. [PMID: 26227148] doi:10.1186/s12874-015-0060-8
33. Goldstein H, Spiegelhalter DJ. League Tables and their limitations: statistical issues in comparisons of institutional performance. Journal of the Royal Statistical Society Series A (Statistics in Society). 1996;159:385-443.
34. Siregar S, Groenwold RH, Jansen EK, Bots ML, van der Graaf Y, van Herwerden LA. Limitations of ranking lists based on cardiac surgery mortality rates. Circ Cardiovasc Qual Outcomes. 2012;5:403-9. [PMID: 22592754] doi:10.1161/CIRCOUTCOMES.111.964460
35. Marshall EC, Spiegelhalter DJ. Reliability of league tables of in vitro fertilisation clinics: retrospective analysis of live birth rates. BMJ. 1998;316:1701-4; discussion 1705. [PMID: 9614016]
36. Efthimiou O, Mavridis D, Riley RD, Cipriani A, Salanti G. Joint synthesis of multiple correlated outcomes in networks of interventions. Biostatistics. 2015;16:84-97. [PMID: 24992934] doi:10.1093/biostatistics/kxu030
37. Hong H, Carlin BP, Chu H, Shamliyan TA, Wang S, Kane RL. A Bayesian missing data framework for multiple continuous outcome mixed treatment comparisons. Methods research report. AHRQ publication no. 13-EHC004-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2013.
38. Nikolakopoulou A, Mavridis D, Salanti G. Planning future studies based on the precision of network meta-analysis results. Stat Med. 2016;35:978-1000. [PMID: 26250759] doi:10.1002/sim.6608
39. Puhan MA, Schünemann HJ, Murad MH, Li T, Brignardello-Petersen R, Singh JA, et al; GRADE Working Group. A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis. BMJ. 2014;349:g5630. [PMID: 25252733] doi:10.1136/bmj.g5630
40. Trinquart L, Abbé A, Ravaud P. Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials. PLoS One. 2012;7:e35219. [PMID: 22536359] doi:10.1371/journal.pone.0035219
41. Mavridis D, Efthimiou O, Leucht S, Salanti G. Publication bias and small-study effects magnified effectiveness of antipsychotics but their relative ranking remained invariant. J Clin Epidemiol. 2016;69:161-9. [PMID: 26210055] doi:10.1016/j.jclinepi.2015.05.027
42. Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux L, Van Noord M, et al. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med. 2011;155:772-85. [PMID: 22147715] doi:10.7326/0003-4819-155-11-201112060-00009
43. Cipriani A, Barbui C, Salanti G, Rendell J, Brown R, Stockton S, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet. 2011;378:1306-15. [PMID: 21851976] doi:10.1016/S0140-6736(11)60873-8
44. Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet. 2009;373:746-58. [PMID: 19185342] doi:10.1016/S0140-6736(09)60046-5
45. Imamura M, Abrams P, Bain C, Buckley B, Cardozo L, Cody J, et al. Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence. Health Technol Assess. 2010;14:1-188, iii-iv. [PMID: 20738930] doi:10.3310/hta14400
46. Bash LD, Buono JL, Davies GM, Martin A, Fahrbach K, Phatak H, et al. Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation. Cardiovasc Drugs Ther. 2012;26:167-79. [PMID: 22418856] doi:10.1007/s10557-012-6374-4
47. Dunkley AJ, Charles K, Gray LJ, Camosso-Stefinovic J, Davies MJ, Khunti K. Effectiveness of interventions for reducing diabetes and cardiovascular disease risk in people with metabolic syndrome: systematic review and mixed treatment comparison meta-analysis. Diabetes Obes Metab. 2012;14:616-25. [PMID: 22284386] doi:10.1111/j.1463-1326.2012.01571.x
48. Jalota L, Kalira V, George E, Shi YY, Hornuss C, Radke O, et al; Perioperative Clinical Research Core. Prevention of pain on injection of propofol: systematic review and meta-analysis. BMJ. 2011;342:d1110. [PMID: 21406529] doi:10.1136/bmj.d1110
49. Roskell NS, Lip GY, Noack H, Clemens A, Plumb JM. Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate. Thromb Haemost. 2010;104:1106-15. [PMID: 20967400] doi:10.1160/TH10-10-0642
50. van de Kerkhof P, de Peuter R, Ryttov J, Jansen JP. Mixed treatment comparison of a two-compound formulation (TCF) product containing calcipotriol and betamethasone dipropionate with other topical treatments in psoriasis vulgaris. Curr Med Res Opin. 2011;27:225-38. [PMID: 21142833] doi:10.1185/03007995.2010.541005
51. Woo G, Tomlinson G, Nishikawa Y, Kowgier M, Sherman M, Wong DK, et al. Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses. Gastroenterology. 2010;139:1218-29. [PMID: 20600036] doi:10.1053/j.gastro.2010.06.042
52. Anothaisintawee T, Attia J, Nickel JC, Thammakraisorn S, Numthavaj P, McEvoy M, et al. Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA. 2011;305:78-86. [PMID: 21205969] doi:10.1001/jama.2010.1913
53. Bottomley JM, Taylor RS, Ryttov J. The effectiveness of two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of moderately severe scalp psoriasis: a systematic review of direct and indirect evidence. Curr Med Res Opin. 2011;27:251-68. [PMID: 21142838] doi:10.1185/03007995.2010.541022
54. Guyot P, Taylor P, Christensen R, Pericleous L, Poncet C, Lebmeier M, et al. Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis. Arthritis Res Ther. 2011;13:R204. [PMID: 22151924] doi:10.1186/ar3537
55. Liu SC, Tu YK, Chien MN, Chien KL. Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis. Diabetes Obes Metab. 2012;14:810-20. [PMID: 22486990] doi:10.1111/j.1463-1326.2012.01606.x
56. Wang H, Huang T, Jing J, Jin J, Wang P, Yang M, et al. Effectiveness of different central venous catheters for catheter-related infections: a network meta-analysis. J Hosp Infect. 2010;76:1-11. [PMID: 20638155] doi:10.1016/j.jhin.2010.04.025
57. Cooper NJ, Sutton AJ, Lu G, Khunti K. Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation. Arch Intern Med. 2006;166:1269-75. [PMID: 16801509]
58. Dakin H, Fidler C, Harper C. Mixed treatment comparison meta-analysis evaluating the relative efficacy of nucleos(t)ides for treatment of nucleos(t)ide-naive patients with chronic hepatitis B. Value Health. 2010;13:934-45. [PMID: 20825624] doi:10.1111/j.1524-4733.2010.00777.x
59. Launois R, Avouac B, Berenbaum F, Blin O, Bru I, Fautrel B, et al. Comparison of certolizumab pegol with other anticytokine agents for treatment of rheumatoid arthritis: a multiple-treatment Bayesian meta-analysis. J Rheumatol. 2011;38:835-45. [PMID: 21239748] doi: 10.3899/jrheum.100665
60. Reich K, Burden AD, Eaton JN, Hawkins NS. Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials. Br J Dermatol. 2012;166: 179-88. [PMID: 21910698] doi:10.1111/j.1365-2133.2011.10583.x
61. Roskell NS, Zimovetz EA, Rycroft CE, Eckert BJ, Tyas DA. Annualized relapse rate of first-line treatments for multiple sclerosis: a meta-analysis, including indirect comparisons versus fingolimod. Curr Med Res Opin. 2012;28:767-80. [PMID: 22462530] doi:10.1185/03007995.2012.681637
62. Sciarretta S, Palano F, Tocci G, Baldini R, Volpe M. Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk. Arch Intern Med. 2011;171:384-94. [PMID: 21059964] doi:10.1001/archinternmed.2010.427
63. Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ. 2011;342:c7086. [PMID: 21224324] doi:10.1136/bmj.c7086
64. Bangalore S, Kumar S, Kjeldsen SE, Makani H, Grossman E, Wetterslev J, et al. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol. 2011;12:65-82. [PMID: 21123111] doi:10.1016/S1470-2045(10)70260-6
65. Daniels JP, Middleton LJ, Champaneria R, Khan KS, Cooper K, Mol BW, et al; International Heavy Menstrual Bleeding IPD Meta-analysis Collaborative Group. Second generation endometrial ablation techniques for heavy menstrual bleeding: network metaanalysis. BMJ. 2012;344:e2564. [PMID: 22529302] doi:10.1136/bmj.e2564
66. Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA. 2003;289:2534-44. [PMID: 12759325]
67. Roskell NS, Beard SM, Zhao Y, Le TK. A meta-analysis of pain response in the treatment of fibromyalgia. Pain Pract. 2011;11:516-27. [PMID: 21199320] doi:10.1111/j.1533-2500.2010.00441.x
68. Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. 2010:CD002898. [PMID: 21154352] doi:10.1002/14651858.CD002898.pub4
69. Coleman CI, Baker WL, Kluger J, White CM. Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials. J Hypertens. 2008;26:622-9. [PMID: 18327066] doi:10.1097/HJH.0b013e3282f3ef5e
70. Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet. 2007;369:201-7. [PMID: 17240286]
71. Gross JL, Kramer CK, Leitão CB, Hawkins N, Viana LV, Schaan BD, et al; Diabetes and Endocrinology Meta-analysis Group (DEMA). Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis. Ann Intern Med. 2011;154:672-9. [PMID: 21576535] doi:10.7326/0003-4819-154-10-201105170-00007
72. Gurusamy KS, Pissanou T, Pikhart H, Vaughan J, Burroughs AK, Davidson BR. Methods to decrease blood loss and transfusion requirements for liver transplantation. Cochrane Database Syst Rev. 2011:CD009052. [PMID: 22161443] doi:10.1002/14651858.CD009052.pub2
73. Jansen JP, Bergman GJ, Huels J, Olson M. The efficacy of bisphosphonates in the prevention of vertebral, hip, and nonvertebralnonhip fractures in osteoporosis: a network meta-analysis. Semin Arthritis Rheum. 2011;40:275-84.e1-2. [PMID: 20828791] doi:10.1016/j.semarthrit.2010.06.001
74. Littlewood KJ, Higashi K, Jansen JP, Capkun-Niggli G, Balp MM, Doering G, et al. A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis. J Cyst Fibros. 2012;11:419-26. [PMID: 22717535] doi:10.1016/j.jcf.2012.03.010
75. Numthavaj P, Thakkinstian A, Dejthevaporn C, Attia J. Corticosteroid and antiviral therapy for Bell's palsy: a network meta-analysis. BMC Neurol. 2011;11:1. [PMID: 21208452] doi:10.1186/1471-2377-11-1
76. Phung OJ, Sood NA, Sill BE, Coleman CI. Oral anti-diabetic drugs for the prevention of type 2 diabetes. Diabet Med. 2011;28: 948-64. [PMID: 21429006] doi:10.1111/j.1464-5491.2011.03303.x
77. Uthman OA, Abdulmalik J. Comparative efficacy and acceptability of pharmacotherapeutic agents for anxiety disorders in children and adolescents: a mixed treatment comparison meta-analysis. Curr Med Res Opin. 2010;26:53-9. [PMID: 19905879] doi:10.1185/03007990903416853
78. Van den Bruel A, Gailly J, Devriese S, Welton NJ, Shortt AJ, Vrijens F. The protective effect of ophthalmic viscoelastic devices on endothelial cell loss during cataract surgery: a meta-analysis using mixed treatment comparisons. Br J Ophthalmol. 2011;95:5-10. [PMID: 19965836] doi:10.1136/bjo.2009.158360
79. Vieira MC, Kumar RN, Jansen JP. Comparative effectiveness of efavirenz, protease inhibitors, and raltegravir-based regimens as first-line treatment for HIV-infected adults: a mixed treatment comparison. HIV Clin Trials. 2011;12:175-89. [PMID: 22044854] doi:10.1310/HCT1204-175
80. Yu CH, Beattie WS. The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG: a meta-analysis. Can J Anaesth. 2006;53:906-18. [PMID: 16960269]
81. Baker WL, Baker EL, Coleman CI. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis. Pharmacotherapy. 2009;29:891-905. [PMID: 19637942] doi:10.1592/phco.29.8.891
82. Bergman GJ, Hochberg MC, Boers M, Wintfeld N, Kielhorn A, Jansen JP. Indirect comparison of tocilizumab and other biologic agents in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs. Semin Arthritis Rheum. 2010;39:425-41. [PMID: 20223500] doi:10.1016/j.semarthrit.2009.12.002
83. Chang KV, Chen SY, Chen WS, Tu YK, Chien KL. Comparative effectiveness of focused shock wave therapy of different intensity levels and radial shock wave therapy for treating plantar fasciitis: a systematic review and network meta-analysis. Arch Phys Med Rehabil. 2012;93:1259-68. [PMID: 22421623] doi:10.1016/j.apmr.2012.02.023
84. Del Santo F, Maratea D, Fadda V, Trippoli S, Messori A. Treatments for relapsing-remitting multiple sclerosis: summarising current information by network meta-analysis. Eur J Clin Pharmacol. 2012; 68:441-8. [PMID: 22057838] doi:10.1007/s00228-011-1141-1
85. Edwards SJ, Lind T, Lundell L, DAS R. Systematic review: standard- and double-dose proton pump inhibitors for the healing of severe erosive oesophagitis - a mixed treatment comparison of randomized controlled trials. Aliment Pharmacol Ther. 2009;30:547-56. [PMID: 19558609] doi:10.1111/j.1365-2036.2009.04077.x
86. Edwards SJ, Clarke MJ, Wordsworth S, Welton NJ. Carbapenems versus other betalactams in the treatment of hospitalised patients with infection: a mixed treatment comparison. Curr Med Res Opin. 2009;25:251-61. [PMID: 19210156] doi:10.1185/03007990802633160
87. Jansen JP, Bergman GJ, Huels J, Olson M. Prevention of vertebral fractures in osteoporosis: mixed treatment comparison of bisphosphonate therapies. Curr Med Res Opin. 2009;25:1861-8. [PMID: 19530978] doi:10.1185/03007990903035281
88. Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. J Am Coll Cardiol. 2008;52:1769-81. [PMID: 19022156] doi:10.1016/j.jacc.2008.08.039
89. Thakkinstian A, Attia J, Anothaisintawee T, Nickel JC. a-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome. BJU Int. 2012;110: 1014-22. [PMID: 22471591] doi:10.1111/j.1464-410X.2012.11088.x
90. Thijs V, Lemmens R, Fieuws S. Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke. Eur Heart J. 2008;29:1086-92. [PMID: 18349026] doi:10.1093/eurheartj/ehn106
91. Vejakama P, Thakkinstian A, Lertrattananon D, Ingsathit A, Ngarmukos C, Attia J. Renoprotective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis. Diabetologia. 2012;55:566-78. [PMID: 22189484] doi:10.1007/s00125-011-2398-8
92. Virgili G, Novielli N, Menchini F, Murro V, Giacomelli G. Pharmacological treatments for neovascular age-related macular degeneration: can mixed treatment comparison meta-analysis be useful? Curr Drug Targets. 2011;12:212-20. [PMID: 20887240]
93. Jansen JP. Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisons. Curr Med Res Opin. 2006;22:671-81. [PMID: 16684428]
94. Lam SK, Owen A. Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials. BMJ. 2007;335:925. [PMID: 17932160]
95. Meader N. A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis. Drug Alcohol Depend. 2010;108: 110-4. [PMID: 20074867] doi:10.1016/j.drugalcdep.2009.12.008
96. Owen A. Antithrombotic treatment for the primary prevention of stroke in patients with non valvular atrial fibrillation: a reappraisal of the evidence and network meta analysis. Int J Cardiol. 2010;142: 218-23. [PMID: 20061035] doi:10.1016/j.ijcard.2009.11.045
97. Phung OJ, Kahn SR, Cook DJ, Murad MH. Dosing frequency of unfractionated heparin thromboprophylaxis: a meta-analysis. Chest. 2011;140:374-81. [PMID: 21349929] doi:10.1378/chest.10-3084
98. Jones LJ, Craven PD, Attia J, Thakkinstian A, Wright I. Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2011;96: F45-52. [PMID: 20876595] doi:10.1136/adc.2009.168682
99. Sanches AC, Correr CJ, Venson R, Pontarolo R. Revisiting the efficacy of long-acting insulin analogues on adults with type 1 diabetes using mixed-treatment comparisons. Diabetes Res Clin Pract. 2011;94: 333-9. [PMID: 21992870] doi:10.1016/j.diabres.2011.09.001